rum miRNA 146b-5p a pharmacodynamic biomarker in adult inflammatory bowel disease
The Egyptian journal of Immunology · 2025
DOI: 10.55133/eji.320305 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Egyptian journal of Immunology, 2025. Verfasst von Doaa M A Elzoghby und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Hauptthemen laut MEDLINE: MicroRNAs, Colitis, Ulcerative, Inflammatory Bowel Diseases, Crohn Disease.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) impacts the gastrointestinal tract, resulting in multiple hospitalizations, complications, and diminished quality of life. IBD has two subtypes: Crohn’s Disease (CD) and Ulcerative Colitis (UC). Evidence suggested that immune response dysregulation and genetic susceptibility are the main disease pathogenesis. IBD diagnosis is established by clinical, laboratory, radiological, endoscopic and histological criteria. MiRNA-146 suppresses proinflammatory cytokines and activates T regulatory lymphocytes (Tregs). Serum miRNA-146b-5p targets genes and cytokines responsible for inhibiting autophagy and maintaining cell homeostasis. This study aimed to evaluate the role of miRNA ‐146b‐5p in diagnosis of IBD and response to treatment. The study consisted of sixty 60 participants separated into 3 groups. Blood samples were withdrawn from 20 acute IBD cases before treatment (Group I), 20 Chronic IBD patients on treatment (Group II) and 20 apparently healthy controls (Group III) for assay of miRNA-146b-5p using the Real-Time polymerase chain reaction (PCR), fecal calprotectin and C reactive protein (CRP). The study revealed statistically significant variation between the 3 studied groups according to stool fecal calprotectin, CRP and microRNA-146b-5p (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- Department of Internal Medicine, Faculty of Medicine, Ain Shams University, Cairo, Egypt.
Zitieren
APA
Elzoghby, D. M. A., Mahmoud, N. H., Allam, A. S., Abdallah, A. M., & AbdElGhani, A. M. (2025). rum miRNA 146b-5p a pharmacodynamic biomarker in adult inflammatory bowel disease. The Egyptian journal of Immunology. https://doi.org/10.55133/eji.320305
Vancouver
Elzoghby DMA, Mahmoud NH, Allam AS, Abdallah AM, AbdElGhani AM. rum miRNA 146b-5p a pharmacodynamic biomarker in adult inflammatory bowel disease. The Egyptian journal of Immunology. 2025. doi:10.55133/eji.320305
BibTeX
@article{Elzoghby2025,
author = {Elzoghby, Doaa M A and Mahmoud, Nermine H and Allam, Ahmed S and Abdallah, Aya M and AbdElGhani, Amani M},
title = {rum miRNA 146b-5p a pharmacodynamic biomarker in adult inflammatory bowel disease},
journal = {The Egyptian journal of Immunology},
year = {2025},
doi = {10.55133/eji.320305}
}
EUVIMED